Deanna Petersen

Biography

Deanna is a broadly skilled senior executive with leadership experience in global business development and strategic planning. Deanna previously was the head of business development for Shire’s rare disease business where she and her team identified and evaluated new business opportunities, and negotiated and executed more than 40 transactions in 5 years (public and private M&A, licenses and other partnerships), including a $4.2 billion dollar acquisition of ViroPharma. Prior to joining Shire, Deanna was Vice President of Business Development at Agenus Inc. and at Coley Pharmaceutical Group. Deanna is on the Board of Directors for Tecogen, Inc. (TGEN) and was previously on Boards for Armagen, American DG Energy (ADGE), the Massachusetts Biotechnology Association, the Boston Chapter of the Healthcare Businesswomen’s Association and for the Boston BioPharma Executive Council. Deanna is a broadly skilled senior executive with leadership experience in global business development and strategic planning. Deanna previously was the head of business development for Shire’s rare disease business where she and her team identified and evaluated new business opportunities, and negotiated and executed more than 40 transactions in 5 years (public and private M&A, licenses and other partnerships), including a $4.2 billion dollar acquisition of ViroPharma. Prior to joining Shire, Deanna was Vice President of Business Development at Agenus Inc. and at Coley Pharmaceutical Group. Deanna is on the Board of Directors for Tecogen, Inc. (TGEN) and was previously on Boards for Armagen, American DG Energy (ADGE), the Massachusetts Biotechnology Association, the Boston Chapter of the Healthcare Businesswomen’s Association and for the Boston BioPharma Executive Council.

Research Interest

Biochemistry